PubRank

H Refsum

Author PubWeight™ 181.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 2000 5.61
2 Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997 5.35
3 Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998 4.48
4 Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2007 2.96
5 Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000 2.53
6 The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000 2.45
7 Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998 2.41
8 Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995 2.36
9 Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995 2.31
10 Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998 2.31
11 Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001 2.13
12 Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993 2.07
13 Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993 2.01
14 Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989 1.85
15 Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 2001 1.84
16 Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995 1.79
17 Vitamin B12 and folate deficiency in later life. Age Ageing 2004 1.67
18 Coffee consumption and plasma total homocysteine: The Hordaland Homocysteine Study. Am J Clin Nutr 1997 1.58
19 Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium. Acta Radiol 2001 1.55
20 A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis 1998 1.50
21 Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. J Pediatr 1996 1.47
22 Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006 1.46
23 Impact of the ultrarapid CYP2C19*17 allele on serum concentration of escitalopram in psychiatric patients. Clin Pharmacol Ther 2007 1.43
24 Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology 2008 1.39
25 Contributions of a transient outward current to repolarization in human atrium. Am J Physiol 1989 1.36
26 Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int 1999 1.31
27 Homocysteine and its disulfide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 2000 1.30
28 Serum concentrations of risperidone and 9-OH risperidone following intramuscular injection of long-acting risperidone compared with oral risperidone medication. Acta Psychiatr Scand 2006 1.27
29 Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine. Circulation 2000 1.23
30 Total homocysteine and cardiovascular disease. J Intern Med 1999 1.23
31 Plasma total cysteine as a risk factor for vascular disease: The European Concerted Action Project. Circulation 2001 1.20
32 Underestimation of the importance of homocysteine as a risk factor for cardiovascular disease in epidemiological studies. J Cardiovasc Risk 2001 1.17
33 Biological and environmental determinants of plasma homocysteine. Semin Thromb Hemost 2000 1.13
34 Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet 1997 1.13
35 Signs of impaired cognitive function in adolescents with marginal cobalamin status. Am J Clin Nutr 2000 1.12
36 Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease. Br J Ophthalmol 2000 1.11
37 Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. J Clin Invest 1996 1.09
38 Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997 1.02
39 Determinants of cobalamin status in newborns. Pediatrics 2001 1.01
40 Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 1999 1.01
41 Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate. Clin Pharmacol Ther 1991 1.00
42 Methylenetetrahydrofolate reductase 677 C-->T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 2000 1.00
43 Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease. Scand J Clin Lab Invest 1997 1.00
44 Plasma vitamin B12 status and cerebral white-matter lesions. J Neurol Neurosurg Psychiatry 2008 0.99
45 Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation. Pharmacol Toxicol 1988 0.97
46 Homocysteine and methylmalonic acid levels in pregnant Nepali women. Should cobalamin supplementation be considered? Eur J Clin Nutr 2001 0.97
47 Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 1990 0.96
48 Radioenzymic determination of homocysteine in plasma and urine. Clin Chem 1985 0.96
49 The 677C-->T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 1997 0.95
50 Experimental hypothermia: effects of core cooling and rewarming on hemodynamics, coronary blood flow, and myocardial metabolism in dogs. Anesth Analg 1994 0.95
51 The Hordaland Homocysteine Studies. Lipids 2001 0.95
52 Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 1999 0.94
53 Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study. Am J Clin Nutr 1999 0.94
54 Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med 2010 0.94
55 Four common mutations of the cystathionine beta-synthase gene detected by multiplex PCR and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 1999 0.92
56 Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study. J Neurol Neurosurg Psychiatry 2006 0.91
57 Recurrent nerve/ansa cervicalis nerve anastomosis: a treatment alternative in unilateral recurrent nerve paralysis. Acta Otolaryngol 1992 0.91
58 Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997 0.91
59 Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients. Eur J Clin Pharmacol 2008 0.90
60 Variability and determinants of total homocysteine concentrations in plasma in an elderly population. Clin Chem 1998 0.90
61 Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug. Cardiovasc Res 1981 0.90
62 Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system. J Nutr 1996 0.89
63 Methylmalonic acid and homocysteine in plasma as indicators of functional cobalamin deficiency in infants on macrobiotic diets. Pediatr Res 1994 0.89
64 Effect of physiological doses of oral vitamin B12 on plasma homocysteine: a randomized, placebo-controlled, double-blind trial in India. Eur J Clin Nutr 2010 0.89
65 Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr 2005 0.89
66 Cardiac electrophysiology, arrhythmogenic mechanisms and roentgen contrast media. Acta Radiol Suppl 1995 0.88
67 Risk of persistent cobalamin deficiency in adolescents fed a macrobiotic diet in early life. Am J Clin Nutr 1999 0.88
68 Influence of beta-adrenergic and cholinergic blockade on the electrophysiological effects of melperone in the dog heart in situ. Cardiovasc Res 1981 0.87
69 Homocysteine export from cells cultured in the presence of physiological or superfluous levels of methionine: methionine loading of non-transformed, transformed, proliferating, and quiescent cells in culture. J Cell Physiol 1991 0.87
70 Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Invest 2004 0.87
71 The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. Nutr Metab Cardiovasc Dis 2011 0.87
72 Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 1998 0.87
73 Effect of methotrexate on homocysteine and other sulfur compounds in tissues of rats fed a normal or a defined, choline-deficient diet. Cancer Chemother Pharmacol 1988 0.86
74 Homocysteine in frozen plasma samples. A short cut to establish hyperhomocysteinaemia as a risk factor for arteriosclerosis? Scand J Clin Lab Invest 1993 0.86
75 The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study. Atherosclerosis 2001 0.85
76 Qualitative differences between beta-adrenergic and alpha-adrenergic inotropic effects in rat heart muscle. Acta Pharmacol Toxicol (Copenh) 1978 0.85
77 Cardiac electrophysiologic and hemodynamic effects related to plasma levels of bupivacaine in the dog. Anesth Analg 1985 0.85
78 Methotrexate sensitivity in Down's syndrome: a hypothesis. Cancer Chemother Pharmacol 1990 0.85
79 Folate depletion induced by methotrexate affects methionine synthase activity and its susceptibility to inactivation by nitrous oxide. J Pharmacol Exp Ther 1997 0.85
80 Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med 1992 0.85
81 Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells. Prostaglandins Leukot Essent Fatty Acids 2012 0.85
82 Homocysteine remethylation during nitrous oxide exposure of cells cultured in media containing various concentrations of folates. J Pharmacol Exp Ther 1992 0.83
83 Co-ordinate variations in methylmalonyl-CoA mutase and methionine synthase, and the cobalamin cofactors in human glioma cells during nitrous oxide exposure and the subsequent recovery phase. Biochem J 1999 0.83
84 Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease. J Intern Med 2007 0.83
85 Pericardial pressure assessed by right atrial pressure: a basis for calculation of left ventricular transmural pressure. Am Heart J 1984 0.83
86 Analysis of single-strand conformation polymorphism by capillary electrophoresis with laser-induced fluorescence detection using short-chain polyacrylamide as sieving medium. Anal Biochem 1997 0.83
87 Effects of thoracic epidural analgesia on cardiovascular function and plasma concentration of free fatty acids and catecholamines in the dog. Acta Anaesthesiol Scand 1984 0.83
88 Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives. Pediatr Res 1996 0.83
89 Cardiac electrophysiology during hypothermia. Implications for medical treatment. Arctic Med Res 1991 0.83
90 Cardiovascular safety of MnDPDP and MnCl2. Acta Radiol 1997 0.83
91 Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subjects. Circ Res 2001 0.83
92 The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs. Pharmacopsychiatry 2006 0.83
93 Contrast media-induced ventricular fibrillation: an experimental study of the effects of dimeric contrast media during wedged catheter injection in dogs. Acad Radiol 1994 0.83
94 Class III antiarrhythmic action linked with positive inotropy: acute electrophysiological and inotropic effects of amiodarone in vitro. Pharmacol Toxicol 1990 0.83
95 Disruption of a regulatory system involving cobalamin distribution and function in a methionine-dependent human glioma cell line. J Biol Chem 1998 0.82
96 Monitoring cobalamin inactivation during nitrous oxide anesthesia by determination of homocysteine and folate in plasma and urine. Clin Pharmacol Ther 1991 0.82
97 Comparison of the electrophysiological effects of two neuroleptics, melperone and thioridazine, on isolated rat atria. Eur J Pharmacol 1978 0.82
98 Anti-arrhythmic action of melperone in the dog heart in situ. Acta Pharmacol Toxicol (Copenh) 1979 0.82
99 Sodium addition to nonionic contrast media. Effects on cardiac monophasic action potentials and hemodynamics in a dog model. Invest Radiol 1991 0.81
100 Plasma levels and cardiac electrophysiological effects of melperone in the dog. Eur J Pharmacol 1982 0.81
101 Development and reversion of methionine dependence in a human glioma cell line: relation to homocysteine remethylation and cobalamin status. Cancer Res 1994 0.81
102 [Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy]. Nord Med 1989 0.81
103 Effects of temperature on cycle length dependent changes and restitution of action potential duration in guinea pig ventricular muscle. Cardiovasc Res 1993 0.81
104 Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen. Int J Cancer 1995 0.81
105 Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am J Clin Nutr 1996 0.81
106 Elevated plasma total homocysteine and C677T mutation of the methylenetetrahydrofolate reductase gene in patients with spina bifida. QJM 1997 0.81
107 Experimental hypothermia and rewarming: changes in mechanical function and metabolism of rat hearts. J Appl Physiol (1985) 1996 0.81
108 Electrophysiological effects of thoracic epidural analgesia in the dog heart in situ. Cardiovasc Res 1983 0.81
109 The mode of antiarrhythmic action of melperone. Acta Pharmacol Toxicol (Copenh) 1982 0.81
110 Effects of N-acetylprocainamide as compared with procainamide in isolated rat atria. Eur J Pharmacol 1975 0.80
111 Ventricular diastolic pressure-volume relations and the pericardium. Effects of changes in blood volume and pericardial effusion in dogs. Circulation 1981 0.80
112 Plasma total homocysteine is influenced by prandial status in humans: the Hordaland Hhomocysteine Sstudy. J Nutr 2001 0.80
113 Changes in ventricular fibrillation threshold during acute hypothermia. A model for future studies. J Basic Clin Physiol Pharmacol 1996 0.80
114 Acute and long-term effects of high-dose methotrexate treatment on homocysteine in plasma and urine. Cancer Res 1986 0.80
115 Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria. Br J Pharmacol 1991 0.80
116 Rate-dependent differences in dog epi- and endocardial monophasic action potential configuration in vivo. Am J Physiol 1991 0.80
117 Identification of a novel CYP2C19-mediated metabolic pathway of S-citalopram in vitro. Drug Metab Dispos 2009 0.80
118 Absorption and excretion of iodixanol after intragastric administration to rats. Acta Radiol Suppl 1995 0.80
119 Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype. Am J Med Genet 2001 0.79
120 Prolonged ventricular refractoriness and action potential duration after beta-adrenoreceptor blockade in the dog heart in situ. J Cardiovasc Pharmacol 1982 0.79
121 The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine. J Pediatr 1998 0.79
122 Mechanism of ECG changes and arrhythmogenic properties of low osmolality contrast media during coronary arteriography in dog. Cardiovasc Res 1990 0.79
123 The action of practolol on the isolated rat atrium. Acta Pharmacol Toxicol (Copenh) 1972 0.79
124 Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs. Cardiovasc Res 1981 0.79
125 Proliferation, migration and invasion of human glioma cells exposed to antifolate drugs. Int J Cancer 1993 0.79
126 Determination of in vivo protein binding of homocysteine and its relation to free homocysteine in the liver and other tissues of the rat. J Biol Chem 1986 0.79
127 Ventricular diastolic pressure-volume shifts during acute ischemic left ventricular failure in dogs. J Am Coll Cardiol 1984 0.79
128 Plasma sulfur amino acids and stearoyl-CoA desaturase activity in two Caucasian populations. Prostaglandins Leukot Essent Fatty Acids 2013 0.79
129 Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration. Clin Chem 1993 0.79
130 Quantification of effect of pericardium on LV diastolic PV relation in dogs. Am J Physiol 1987 0.78
131 Diet, an independent determinant for plasma total homocysteine. A cross sectional study of Norwegian workers on platforms in the North Sea. Eur J Clin Nutr 1998 0.78
132 Vasodilator and inotropic effects of the antiarrhythmic drug melperone. J Cardiovasc Pharmacol 1982 0.78
133 The interaction between nitrous oxide and cobalamin. Biochemical effects and clinical consequences. Acta Anaesthesiol Scand 1994 0.78
134 Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading. Clin Chem 1993 0.78
135 The pericardial hypothesis: a mechanism of acute shifts of the left ventricular diastolic pressure-volume relation. Clin Physiol 1985 0.78
136 Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs. Acad Radiol 1997 0.78
137 Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele. Eur J Clin Pharmacol 2008 0.78
138 Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure. Acta Radiol 1997 0.78
139 Chemical mismatch cleavage combined with capillary electrophoresis: detection of mutations exon 8 of the cystathionine beta-synthase gene. Clin Chem 1998 0.78
140 Evaluation of indicators of cobalamin deficiency defined as cobalamin-induced reduction in increased serum methylmalonic acid. Clin Chem 2000 0.78
141 Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs. J Cardiovasc Pharmacol 1992 0.78
142 Aspects of the relative roles of peripheral vasoconstriction and vagal bradycardia in the establishment of the "diving reflex" in ducks. Acta Physiol Scand 1974 0.78
143 Vagus-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockade. J Cardiovasc Pharmacol 1982 0.78
144 Cardiac effects of iodixanol compared to those of other nonionic and ionic contrast media on the isolated rat heart. Acta Radiol Suppl 1995 0.78
145 Visipaque is isotonic to human and rat blood plasma. Acta Radiol Suppl 1995 0.78
146 A clinical study of the cognitive effects of benzodiazepines in psychogeriatric patients. Pharmacopsychiatry 2013 0.77
147 Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ. J Cardiovasc Pharmacol 1986 0.77
148 Population determinants of homocysteine. Am J Clin Nutr 2001 0.77
149 Simultaneous determination of methylenetetrahydrofolate reductase C677T and factor V G1691A genotypes by mutagenically separated PCR and multiple-injection capillary electrophoresis. Clin Chem 1998 0.77
150 Preoperative methionine loading enhances restoration of the cobalamin-dependent enzyme methionine synthase after nitrous oxide anesthesia. Anesthesiology 1994 0.77
151 Iodinated radiographic contrast media inhibit shear stress- and agonist-evoked release of NO by the endothelium. Br J Pharmacol 1999 0.77
152 Evaluation of novel assays in clinical chemistry: quantification of plasma total homocysteine. Clin Chem 2000 0.77
153 Repeated intracoronary injections of contrast media. Additive hemodynamic and electrophysiologic effects in a dog model. Invest Radiol 1993 0.77
154 Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios. Pharmacopsychiatry 2010 0.77
155 Comparative force-velocity relation and analyses of myosin of dog atria and ventricles. Am J Physiol 1982 0.77
156 A method for simultaneous epicardial monophasic action potential recordings from the dog heart in situ. Acta Pharmacol Toxicol (Copenh) 1984 0.77
157 Left ventricular systolic and diastolic function during coronary arteriography before and after acute left ventricular failure in dogs. A comparison between iodixanol, iohexol and ioxaglate. Acta Radiol 1991 0.77
158 [Post-polio respiratory failure. New manifestations of a forgotten disease]. Tidsskr Nor Laegeforen 1988 0.76
159 Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle. J Cardiovasc Pharmacol 1992 0.76
160 Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle. Cardiovasc Drugs Ther 1992 0.76
161 Disposition of endogenous homocysteine by mouse fibroblast C3H/10T1/2 Cl 8 and the chemically transformed C3H/10T1/2 MCA Cl 16 cells following methotrexate exposure. J Natl Cancer Inst 1986 0.76
162 The effect of nifedipine on the monophasic action potential and refractoriness of the right ventricle of the dog heart in situ after beta-adrenergic receptor blockade. Acta Pharmacol Toxicol (Copenh) 1979 0.76
163 Applications of short-chain polydimethylacrylamide as sieving medium for the electrophoretic separation of DNA fragments and mutation analysis in uncoated capillaries. Anal Biochem 1999 0.76
164 Response of the methionine synthase system to short-term culture with homocysteine and nitrous oxide and its relation to methionine dependence. Int J Cancer 1997 0.76
165 The effect of the temperature of contrast media on cardiac electrophysiology and hemodynamics during coronary arteriography. Invest Radiol 1992 0.76
166 Association between plasma total homocysteine and parental history of cardiovascular disease in children with familial hypercholesterolemia. Circulation 1997 0.76
167 NMR relaxation studies with MnDPDP. Acta Radiol 1997 0.76
168 Coronary endothelium-derived vasodilation during cooling and rewarming of the in situ heart. Can J Physiol Pharmacol 1999 0.76
169 Acute electrophysiologic and blood pressure effects of amiodarone and its solvent in the dog. Acta Pharmacol Toxicol (Copenh) 1986 0.76
170 Cell kinetics of the rat corneal epithelium. APMIS 1992 0.76
171 Palatopharyngoglossoplasty in the treatment of patients with obstructive sleep apnea syndrome. Acta Otolaryngol Suppl 1992 0.76
172 The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol 1998 0.76
173 Plasma concentrations and haemodynamic effects of d-sotalol after beta-blockade in dogs. Pharmacol Toxicol 1990 0.76
174 Calcium-antagonistic and anti-arrhythmic effects of nifedipine on the isolated rat atrium. Acta Pharmacol Toxicol (Copenh) 1975 0.76
175 Electrophysiological and mechanical effects of sulphinpyrazone on isolated rat atria. Clin Physiol 1982 0.76
176 Prevention of some hypothermia induced electromechanical changes by calcium channel blockade. Cardiovasc Res 1994 0.76
177 A comparison between the information in gated and nongated cardiac CT images. J Comput Assist Tomogr 1982 0.75
178 Left and right ventricular diastolic function during acute pericardial tamponade. Clin Physiol 1991 0.75
179 Coffee and homocysteine. Am J Clin Nutr 2000 0.75
180 A novel pathway for the conversion of homocysteine to methionine in eukaryotes. Biochem J 1997 0.75
181 The need for effective contrast agents to enhance the performance of MR imaging. Acta Radiol 1997 0.75
182 Classification of cardioactive drugs in vivo by using programmed electrical stimulation in combination with monophasic action potential recordings at different pacing rates. Acta Med Scand Suppl 1981 0.75
183 Acute cardiotoxicity of gadolinium-based contrast media: findings in the isolated rat heart. Acad Radiol 1997 0.75
184 Electromechanical effects of two low osmolality contrast media, ioxaglate and iohexol, on isolated rat atria. Pharmacol Toxicol 1990 0.75
185 Class III antiarrhythmic action of d-sotalol during hypothermia. Am Heart J 1991 0.75
186 Effect of intracoronary contrast medium on left ventricular diastolic pressure-volume relationships. Am Heart J 1990 0.75
187 Effects of levomepromazine, chlorpromazine and their sulfoxides on isolated rat atria. Eur J Pharmacol 1976 0.75
188 Hemodynamic effects of d-sotalol in acute ischemic heart failure in dogs. Am Heart J 1992 0.75
189 Kinetics of plasma total homocysteine in patients receiving high-dose methotrexate therapy. Clin Chem 1998 0.75
190 Sodium-calcium balance in coronary angiography. Experimental experience with isotonic iodixanol. Ann N Y Acad Sci 1996 0.75
191 An experimental model for the study of transcapillary fluid balance in hypothermia. Arctic Med Res 1991 0.75
192 The effect of a calcium-antagonistic drug, nifedipine, on the rat atrial action potential at different calcium levels. Acta Pharmacol Toxicol (Copenh) 1975 0.75
193 A comparison of the effects of ouabain, noradrenaline and nifedipine on the contractile force of the isolated rat atrium at different calcium levels. Acta Pharmacol Toxicol (Copenh) 1977 0.75
194 The effect of nifedipine on the isolated rat heart. Acta Pharmacol Toxicol (Copenh) 1976 0.75
195 Circulation time and pattern in cerebral angiography using different techniques for general anaesthesia. Acta Radiol Diagn (Stockh) 1966 0.75
196 Role of sodium addition to nonionic contrast medium in preventing ventricular fibrillation during coronary arteriography in dogs. Acad Radiol 1994 0.75
197 Serum homocysteine levels in postmenopausal breast cancer patients treated with tamoxifen. Cancer Lett 1999 0.75
198 [Calcium antagonists]. Tidsskr Nor Laegeforen 1976 0.75
199 Prolonged action potential duration of guinea-pig heart muscle after pethidine. Pharmacol Toxicol 1990 0.75
200 [Routine determination of homocysteine in plasma. A new and improved possibility for risk evaluation and diagnosis of common diseases]. Tidsskr Nor Laegeforen 1992 0.75
201 Correlation between melperone plasma concentrations and changes in the effective refractory period of the right atrium and ventricle of the dog. Acta Pharmacol Toxicol (Copenh) 1979 0.75
202 C677T mutation of methylenetetrahydrofolate reductase gene determined in blood or plasma by multiple-injection capillary electrophoresis and laser-induced fluorescence detection. Clin Chem 1997 0.75
203 Arrhythmogenic, antiarrhythmic and inotropic properties of opioids. Effects of piritramide, pethidine and morphine compared on heart muscle isolated from rats. Pharmacology 1987 0.75
204 The effect of nifedipine on the effective refractory period and excitability of the isolated rat atrium at different calcium levels and frequencies of stimulation. Acta Pharmacol Toxicol (Copenh) 1976 0.75
205 Pentobarbital plasma concentrations and cardiac electrophysiology during prolonged pentobarbital infusion anaesthesia in the dog. Acta Anaesthesiol Scand 1982 0.75
206 Cardiac effects of thoracic epidural morphine caused by increased vagal activity in the dog. Acta Anaesthesiol Scand 1986 0.75
207 Cardiac effects of adding electrolytes and oxygen to iohexol in a dog model of contrast media-induced ventricular fibrillation. Acta Radiol 1995 0.75
208 [Psychiatric complications of L-Dopa treatment of parkinsonism]. Tidsskr Nor Laegeforen 1973 0.75
209 Cardiac effects of coronary arteriography with electrolyte addition to iohexol. A study in dogs with and without heart failure. Acta Radiol 1994 0.75
210 Apparent depression of right ventricular function after selective reduction of left ventricular inotropy: an interpretation of experimental data utilising a computer-based circulatory model. Med Biol Eng Comput 1983 0.75
211 Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs. Am J Emerg Med 1994 0.75
212 Cardioangiography and the hemodynamic effects of iodixanol. Acta Radiol Suppl 1995 0.75
213 Selective coronary artery perfusion in vitro: a method to study cardiac effects of contrast media. Acad Radiol 1997 0.75
214 Comparison of electrophysiological and mechanical effects of droxicainide and lidocaine on heart muscle isolated from rats. Acta Pharmacol Toxicol (Copenh) 1984 0.75
215 Electrophysiological and mechanical effects of contrast media on isolated rat atria. Cardiovasc Res 1980 0.75
216 The effect of calcium and beat interval on the contractile force and refractoriness of the isolated rat atrium in the absence and presence of nifedipine: a possible mechanism for the negative staircase phenomenon. Acta Pharmacol Toxicol (Copenh) 1977 0.75
217 Arrhythmogenic and cardiodepressive effects of contrast media on isolated rat atria. Invest Radiol 1979 0.75
218 The effect of calcium, practolol, atropine and phenoxybenzamine on the rat atrial action potential at threshold and supra-threshold stimulation. Acta Pharmacol Toxicol (Copenh) 1975 0.75
219 The effect of practolol, atropine and phenoxybenzamine on contractile force of isolated rat atria at threshold and suprathreshold stimulation. Acta Pharmacol Toxicol (Copenh) 1974 0.75
220 The iodinated radiographic contrast medium iohexol mimics the vasodilator effect seen with small increases in extracellular K+ in the isolated rabbit central ear artery. Acta Radiol 2006 0.75
221 Vagus- and post-acetylcholine-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockade. Eur Surg Res 1984 0.75
222 Effects of hormones on the plasma levels of the atherogenic amino acid homocysteine. Biochem Soc Trans 1997 0.75
223 [Increased plasma level of homocysteine as cardiovascular risk factor]. Tidsskr Nor Laegeforen 1996 0.75
224 The effect of a calcium-antagonistic drug, nifedipine, on the mechanical and electrical activity of the isolated rat atrium. Acta Pharmacol Toxicol (Copenh) 1975 0.75
225 Sodium-calcium relationships and cardiac function during coronary bolus perfusion. Acta Radiol Suppl 1995 0.75
226 Associations of serum n-3 and n-6 polyunsaturated fatty acids with echocardiographic measures among older adults: the Hoorn Study. Eur J Clin Nutr 2013 0.75
227 Anticholinergic and anti-arrhythmic effects of phenoxybenzamine on the isolated rat atrium. Acta Pharmacol Toxicol (Copenh) 1973 0.75
228 Anticholinergic and cardiodepressive effects of levomepromazine and two of its metabolites on isolated rat atria. Eur J Pharmacol 1976 0.75
229 [Accidental hypothermia]. Tidsskr Nor Laegeforen 1990 0.75
230 Selenium deficiency and cardiac electrophysiological and mechanical function in the rat. Pharmacol Toxicol 1988 0.75
231 Alpha-adrenoceptor blockade and class III antiarrhythmic activity combined: hemodynamic and electrophysiological effects of melperone in the dog. Can J Physiol Pharmacol 1986 0.75
232 Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients. Clin Chem 1999 0.75
233 Calcium, calcium-antagonistic drugs and the heart. Acta Pharmacol Toxicol (Copenh) 1978 0.75
234 Dementia Prevention by Disease-Modification through Nutrition. J Prev Alzheimers Dis 2017 0.75
235 Effect of hyaluronidase on substrate exchange and blood flow in the ischaemic myocardium of the dog. Clin Physiol 1982 0.75
236 [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action]. Tidsskr Nor Laegeforen 1991 0.75
237 Coronary arteriography with an oxygenated contrast medium: cardiac effects in dogs with and without acute ischemic heart failure. Acad Radiol 1996 0.75
238 Additive hemodynamic and electrophysiologic effects of repeated intracoronary contrast media injections in dogs with heart failure. Acad Radiol 1995 0.75
239 Direct pharmacologic and osmolal effects of contrast media on the mechanics of heart muscle isolated from cats. Am Heart J 1984 0.75
240 Methotrexate therapy and nitrous oxide anesthesia. N Engl J Med 1986 0.75
241 Positive inotropy linked with class III antiarrhythmic action: electrophysiological effects of the cardiotonic agent DPI 201-106 in the dog heart in vivo. Cardiovasc Res 1990 0.75
242 Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes. Cardiovasc Res 1992 0.75
243 Cardiac electrophysiological and hemodynamic effects of beta-adrenoceptor blockade and thoracic epidural analgesia in the dog. Anesth Analg 1984 0.75
244 [Possible role of the calcium ion in the pathogenesis of heart arrhythmias]. Tidsskr Nor Laegeforen 1978 0.75
245 Calcium, nifedipine and arrhythmias in isolated rat atria. Acta Pharmacol Toxicol (Copenh) 1979 0.75
246 Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients. Clin Cancer Res 1998 0.75
247 [Sotalol. Beta-blockade and class III antiarrhythmic effect]. Tidsskr Nor Laegeforen 1990 0.75
248 Hemodynamic and metabolic effects of hypothermia and rewarming. Arctic Med Res 1991 0.75
249 Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs. Acad Radiol 1995 0.75
250 [Determination of homocysteine and methylmalonic acid in cobalamin deficiency. Diagnostic problem with a solution?]. Tidsskr Nor Laegeforen 1991 0.75
251 Class III antiarrhythmic action and inotropy: effects of almokalant in acute ischaemic heart failure in dogs. Pharmacol Toxicol 1992 0.75
252 Disposition of homocysteine in rat hepatocytes and in nontransformed and malignant mouse embryo fibroblasts following exposure to inhibitors of S-adenosylhomocysteine catabolism. Cancer Res 1986 0.75
253 Mechanisms for hypothermia-induced increase in contractile force studied by mechanical restitution and post-rest contractions in guinea-pig papillary muscle. Acta Physiol Scand 1993 0.75
254 Acebutolol-induced changes in refractoriness and monophastic action potential of the right ventricle of the dog heart in situ. Cardiovasc Res 1978 0.75
255 Competitive antagonism between phenoxybenzamine and acetylcholine in isolated rat atria. Acta Pharmacol Toxicol (Copenh) 1973 0.75
256 Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs. J Cardiovasc Pharmacol 1982 0.75